Back
ESC Premium Access

A new point-of-care device to measure erythrocyte aggregation: a proof of concept study. LAREHK-1/LAREHK-2

Session: Poster session 4 - Comorbidities and risk for CAD
Topic: CAD and comorbidities
Speaker: Doctor O. Charansonney (Corbeil-Essonnes, FR)
Event: ESC Congress 2016

Congress Presentation

About the speaker

Doctor Olivier Charansonney

Sud-Francilien Hospital Centre, Corbeil-Essonnes (France)
0 follower

25 more presentations in this session

Clinical profile, mortality and implications of antithrombotic therapy in coronary ectasia.

Speaker: Mr A. Marco del Castillo (Madrid, ES)

Access
Abstract
Thumbnail

Expression of the adipocytokine omentin increases in the epicardial adipose tissue of non-obese coronary artery disease patients

Speaker: Doctor K. Harada (Nagoya, JP)

Access
Abstract
Slides
Thumbnail

Assessment of immune mediators in plasma: a new diagnostic tool for detection of coronary artery disease after heart transplantation.

Speaker: Professor C. Bara (Hannover, DE)

Access
Abstract
Thumbnail

Long-term prognosis and potential years-of-life lost by acute coronary syndromes

Speaker: Doctor A. Cordero (Sant Joan d'Alacant, ES)

Access
Abstract
Slides
Thumbnail

the endothelin gene-1 (EDN-1) glu105Glu (rs5369) gene polymorphism in the EDN-1 is associated with risk of developing acute coronary syndrome in mexican patients

Speaker: Doctor O. Gomez Monterrosas (Puebla, MX)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster session 4 - Comorbidities and risk for CAD

Speakers: Doctor O. Charansonney, Mr A. Marco del Castillo, Doctor K. Harada, Professor C. Bara, Doctor A. Cordero...
Access
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb